Singapore markets close in 4 hours 9 minutes

Silo Pharma, Inc. (SILO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.0300+0.0400 (+2.01%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.69M
Enterprise value -1.05M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)84.66
Price/book (mrq)1.08
Enterprise value/revenue 16.11
Enterprise value/EBITDA -0.30

Trading information

Stock price history

Beta (5Y monthly) 1.34
52-week change 3-7.73%
S&P500 52-week change 328.04%
52-week high 33.0500
52-week low 31.2160
50-day moving average 31.8726
200-day moving average 31.6893

Share statistics

Avg vol (3-month) 3196.83k
Avg vol (10-day) 321.86k
Shares outstanding 52.8M
Implied shares outstanding 62.84M
Float 82.54M
% held by insiders 16.35%
% held by institutions 14.51%
Shares short (30 Apr 2024) 4145.58k
Short ratio (30 Apr 2024) 40.36
Short % of float (30 Apr 2024) 45.45%
Short % of shares outstanding (30 Apr 2024) 45.12%
Shares short (prior month 28 Mar 2024) 461.39k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:50
Last split date 315 Sept 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-5,347.41%

Management effectiveness

Return on assets (ttm)-24.86%
Return on equity (ttm)-43.97%

Income statement

Revenue (ttm)72.1k
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-3.63M
Diluted EPS (ttm)-1.1800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)7.67M
Total cash per share (mrq)2.7
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)9.90
Book value per share (mrq)2.12

Cash flow statement

Operating cash flow (ttm)-3.22M
Levered free cash flow (ttm)-1.78M